Celadon Pharmaceuticals Plc (CEL.L)
GBp 19.0
(0.0%)
GBp 19.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -5.94 Million | -6.1 Million | -3.14 Million | -77.57 Thousand | 1981.00 |
| Net Income | -7.14 Million | -17.41 Million | -4.78 Million | -1.05 Million | -151.69 Thousand |
| Depreciation & Amortization | 550 Thousand | 466 Thousand | 319 Thousand | 160.84 Thousand | 33.48 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 285 Thousand | 7.31 Million | - | - | - |
| Change in working capital | -148 Thousand | -648 Thousand | 23 Thousand | 482.94 Thousand | -1080.00 |
| Other non-cash items | 2.04 Million | 4.18 Million | 1.29 Million | 338.42 Thousand | 121.27 Thousand |
| Investing Cash Flow | -341 Thousand | 1.39 Million | -1.24 Million | -697.03 Thousand | - |
| Investments in PPE | -341 Thousand | -2.08 Million | -542 Thousand | -708.24 Thousand | - |
| Acquisitions | - | 3.49 Million | -500 Thousand | 11.21 Thousand | - |
| Investment purchases | - | -18 Thousand | -200 Thousand | - | - |
| Sales/Maturities of investments | - | -3.47 Million | 700 Thousand | - | - |
| Other Investing Activities | -341 Thousand | 3.47 Million | -700 Thousand | - | - |
| Financing Cash Flow | 2.47 Million | 5.94 Million | 7.91 Million | 1.07 Million | 5.82 Million |
| Debt repayment | -1000.00 | -1.51 Million | -174 Thousand | -50 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 2.97 Million | 7.49 Million | 389 Thousand | 1.02 Million | 5.82 Million |
| Other Financing Activities | 32 Thousand | -32 Thousand | 7.69 Million | 50 Thousand | - |
| Accounts receivables | 108 Thousand | -985 Thousand | -2.13 Million | 5891.00 | -1080.00 |
| Accounts payables | -250 Thousand | 355 Thousand | - | - | - |
| Inventory | -6000.00 | -18 Thousand | - | - | - |
| Other working capital | -250 Thousand | - | 2.15 Million | 477.05 Thousand | 32.94 Thousand |
| Cash at beginning of period | 5.06 Million | 3.82 Million | 300 Thousand | 1486.00 | -176.03 Thousand |
| Cash at end of period | 1.25 Million | 5.06 Million | 3.82 Million | 299.47 Thousand | 5.64 Million |
| Capital Expenditure | -341 Thousand | -2.08 Million | -542 Thousand | -708.24 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -3.8 Million | 1.23 Million | 3.52 Million | 297.99 Thousand | 5.82 Million |
| Free Cash Flow | -6.28 Million | -8.18 Million | -3.69 Million | -785.81 Thousand | 1981.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.19 Million | -1.19 Million | -1.41 Million | -7.14 Million | -1.41 Million | -4.3 Million |
| Depreciation & Amortization | 137.5 Thousand | 137.5 Thousand | 137 Thousand | 550 Thousand | 137 Thousand | 260 Thousand |
| Deferred income taxes | - | - | - | - | - | -355 Thousand |
| Stock-based compensation | 27 Thousand | 27 Thousand | -67.5 Thousand | 285 Thousand | -67.5 Thousand | 210 Thousand |
| Change in working capital | 26 Thousand | 26 Thousand | -94 Thousand | -148 Thousand | -94 Thousand | 489 Thousand |
| Other non-cash items | -281 Thousand | -281 Thousand | -45 Thousand | 2.04 Million | -45 Thousand | 605 Thousand |
| Investing Cash Flow | -13 Thousand | -13 Thousand | -66.5 Thousand | -341 Thousand | -66.5 Thousand | -208 Thousand |
| Investments in PPE | -29.5 Thousand | -29.5 Thousand | -66.5 Thousand | -341 Thousand | -66.5 Thousand | -208 Thousand |
| Acquisitions | 33 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 16.5 Thousand | 16.5 Thousand | - | - | - | - |
| Financing Cash Flow | 678.5 Thousand | 678.5 Thousand | 1.37 Million | 2.47 Million | 1.37 Million | -264 Thousand |
| Debt repayment | -4000.00 | - | -5000.00 | -1000.00 | - | -6000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.58 Million | - | 2.97 Million | 2.97 Million | - | - |
| Other Financing Activities | 678.5 Thousand | 678.5 Thousand | 1.37 Million | 32 Thousand | 1.37 Million | -124 Thousand |
| Accounts receivables | 30.5 Thousand | 30.5 Thousand | -92.5 Thousand | 108 Thousand | -92.5 Thousand | 293 Thousand |
| Accounts payables | -89 Thousand | - | -449 Thousand | -250 Thousand | - | 199 Thousand |
| Inventory | -4500.00 | -4500.00 | -1500.00 | -6000.00 | -1500.00 | -3000.00 |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.25 Million | - | 1.61 Million | 5.06 Million | - | 5.06 Million |
| Cash at end of period | -621.5 Thousand | -621.5 Thousand | 1.25 Million | 1.25 Million | -176 Thousand | 1.61 Million |
| Capital Expenditure | -29.5 Thousand | -29.5 Thousand | -66.5 Thousand | -341 Thousand | -66.5 Thousand | -208 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.88 Million | -621.5 Thousand | -352 Thousand | -3.8 Million | -176 Thousand | -3.45 Million |
| Free Cash Flow | -1.31 Million | -1.31 Million | -1.55 Million | -6.28 Million | -1.55 Million | -3.18 Million |
TRUL
HMAAGRO
7525
CAMPUS
SHALIWIR
SUPRAPFSL